321 related articles for article (PubMed ID: 11802042)
1. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
Suskind DL; Tilton A
Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
[TBL] [Abstract][Full Text] [Related]
2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
3. Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.
Møller E; Pedersen SA; Vinicoff PG; Bardow A; Lykkeaa J; Svendsen P; Bakke M
Toxins (Basel); 2015 Jun; 7(7):2481-93. PubMed ID: 26134257
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
Alataş N; Yazgan P; Oztürk A; San I
Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):49-53. PubMed ID: 16763416
[TBL] [Abstract][Full Text] [Related]
5. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
7. Acute sialadenitis secondary to submandibular calculi after botulinum neurotoxin injection for sialorrhea in a child with cerebral palsy.
Yuan M; Shelton J
Am J Phys Med Rehabil; 2011 Dec; 90(12):1064-7. PubMed ID: 22019967
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
Chan KH; Liang C; Wilson P; Higgins D; Allen GC
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
[TBL] [Abstract][Full Text] [Related]
10. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
11. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
Sidebottom AJ; May JE; Madahar AK
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
Sriskandan N; Moody A; Howlett DC
Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
[TBL] [Abstract][Full Text] [Related]
13. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS
J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
[TBL] [Abstract][Full Text] [Related]
14. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
Shariat-Madar B; Chun RH; Sulman CG; Conley SF
Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
[TBL] [Abstract][Full Text] [Related]
15. Does motor performance matter in botulinum toxin efficacy for drooling?
Erasmus CE; Scheffer AR; van Hulst K; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
Pediatr Neurol; 2011 Aug; 45(2):95-9. PubMed ID: 21763949
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided injection of botulinum toxin A into the submandibular gland in children and young adults with sialorrhoea.
Gok G; Cox N; Bajwa J; Christodoulou D; Moody A; Howlett DC
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):231-3. PubMed ID: 22939893
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
20. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
